GABRA3: A potential target for neurodegenerative diseases (G2556)
GABRA3: A potential target for neurodegenerative diseases
GABA(A) receptors, also known as GABA receptors, are a family of ion channels that play a crucial role in the regulation of neural signaling. These receptors are found throughout the central and peripheral nervous systems and are involved in the transmission of inhibitory signals , which are essential for maintaining the stability and integrity of neural circuits. GABA(A) receptors have been implicated in a wide range of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. In this article, we will explore the biology of GABA(A) receptors and their potential as drug targets in neurodegenerative diseases.
GABA(A) receptors are composed of an extracellular domain that includes a long alpha helix, two beta helices, and a gamma helix located on the inner side of the cell membrane. These beta helices form a spatial scaffold on the inside of the cell membrane, allowing GABA(A) receptors to bind to many different types of ligands. GABA(A) receptor ligands include GABA, GABA-binding protein, GABA-伪 binding protein, etc. GABA(A) receptor binding to these ligands is reversible, and this binding is highly variable. The binding of GABA(A) receptor ligands will lead to changes in intracellular GABA levels, thereby affecting the activity state of neurons.
GABA(A) receptors play an important role in the nervous system, including regulating the excitability balance of neurons, maintaining the stability of information transmission, and participating in various signaling pathways. For example, GABA(A) receptors can regulate the excitability balance of neurons, allowing neurons to produce different outputs under different input signals. GABA(A) receptors can also be involved in regulating synaptic transmission efficiency and participating in interactions between neurons.
However, GABA(A) receptors are also involved in the development of many neurological degenerative diseases. For example, GABA(A) receptors are associated with neuronal apoptosis, which plays an important role in neurological degenerative diseases. GABA(A) receptors are also associated with oxidative stress in neurons, an important factor in neurological degenerative diseases.
Currently, GABA(A) receptors have become a popular target in the treatment of neurological degenerative diseases. Researchers are exploring the use of various methods to agonize GABA(A) receptors to treat neurological degenerative diseases. Some studies have demonstrated that GABA(A) receptor agonists have good therapeutic effects, but some studies have not achieved the expected results.
To better understand the role of GABA(A) receptors in neurological degenerative diseases, researchers are working to uncover how these receptors work. They are exploring the ligand binding, signaling and modification of GABA(A) receptors after ligand binding. These studies are of great significance for understanding the role of GABA(A) receptors in neurological degenerative diseases and providing new targets for the treatment of these diseases.
The role of GABA(A) receptors in neurological degenerative diseases does not end there. These receptors are also involved in neuronal memory and learning. GABA(A) receptors can regulate synaptic plasticity between neurons, thereby affecting the transmission of information between neurons. GABA(A) receptors can also regulate the excitability balance of neurons, thereby affecting the activity state of neurons during learning and memory.
In addition, GABA(A) receptors are also related to neuronal damage and regeneration. GABA(A) receptors are involved in regulating neuronal apoptosis and regeneration after neuronal injury. GABA(A) receptors can also regulate the morphology and function of new neuron synapses, thereby providing an important biological basis for neuron regeneration.
In summary, GABA(A) receptors play an important role in neurological degenerative diseases. These receptors are closely related to processes such as neuronal excitability balance, information transmission, apoptosis and regeneration. Therefore, the GABA(A) receptor is a very attractive drug target and
Protein Name: Gamma-aminobutyric Acid Type A Receptor Subunit Alpha3
Functions: GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel
More Common Targets
GABRA4 | GABRA5 | GABRA6 | GABRB1 | GABRB2 | GABRB3 | GABRD | GABRE | GABRG1 | GABRG2 | GABRG3 | GABRG3-AS1 | GABRP | GABRQ | GABRR1 | GABRR2 | GABRR3 | GACAT1 | GACAT2 | GACAT3 | GAD1 | GAD2 | GADD45A | GADD45B | GADD45G | GADD45GIP1 | GADL1 | GAGE1 | GAGE10 | GAGE12B | GAGE12C | GAGE12D | GAGE12F | GAGE12G | GAGE12H | GAGE12J | GAGE2A | GAGE2B | GAGE2C | GAGE2D | GAGE4 | GAGE5 | GAGE6 | GAGE7 | GAGE8 | GAK | GAL | GAL3ST1 | GAL3ST2 | GAL3ST3 | GAL3ST4 | Galanin receptor | GALC | GALE | GALK1 | GALK2 | GALM | GALNS | GALNT1 | GALNT10 | GALNT11 | GALNT12 | GALNT13 | GALNT13-AS1 | GALNT14 | GALNT15 | GALNT16 | GALNT17 | GALNT18 | GALNT2 | GALNT3 | GALNT4 | GALNT5 | GALNT6 | GALNT7 | GALNT7-DT | GALNT8 | GALNT9 | GALNT9-AS1 | GALNTL5 | GALNTL6 | GALP | GALR1 | GALR2 | GALR3 | GALT | Gamma Crystallin | Gamma-Aminobutyric acid type B receptor | Gamma-aminobutyric-acid A receptor, Rho | gamma-delta T Cell Receptor (TCR) Complex | Gamma-glutamyl transferase | gamma-Secretase | Gamma-tubulin complex | GAMT | GAN | GANAB | GANC | Gap junction Connexin ( | Gap Junction Protein | GAP43